147994 Readiness to change HIV/HCV risk behavior among young African American IDUs

Wednesday, November 7, 2007: 2:50 PM

Edward Morse, PhD , Pediatrics, Tulane University, New Orleans, LA
Patricia M. Morse, PhD , Psychiatry, LSU Health Sciences Center, New Orleans, LA
Samuel Burgess, MA, MPH , Louisiana Office of Public Health, New Orleans, LA
Stan Hoogerwerf, MA , Psychiatry, LSU Health Sciences Center, New Orleans, LA
Objective: To examine the differential effects of self-efficacy and self-esteem on stimulating readiness to change HIV/HCV sexual and drug use risk behaviors in a cohort of young African American IDUs participating in a longitudinal study comparing the relative efficacy of 3 HIV/HCV risk reduction interventions. Methods: As part of a NIDA-funded risk reduction intervention study 211 incarcerated young African American IDUs were randomized to one of three intervention arms (counseling and testing (CT), pharmacy syringe purchase (PSP), and a client centered behavioral intervention (CCBI)). HIV, HCV, and Chlamydia laboratory data as well as baseline interview data measuring readiness to change, self-esteem, self-efficacy, and sexual and drug use risk behaviors were compared to parallel data gathered 6 months post incarceration. Results: At 6 month follow-up, syringe sharing was significantly reduced across all interventions by at least 25%. Increased self-efficacy and self-esteem resulted in increased readiness to change (r=.72; p<.01; r=.68; p<.01 respectively) which was significantly positively associated with HIV/HCV risk reduction (r=.71; p<.01). Conclusions: HIV/HCV risk reduction interventions that include increasing self-efficacy and self-esteem are likely to result in significant HIV/HCV risk behavior change and should be included in intervention and prevention efforts

Learning Objectives:
1. Examine importance of self-esteem and self-efficacy in the development of HIV/HCV interventions. 2. Develop a risk reduction plan for IDUs

Keywords: Intravenous Drug Use, HIV/AIDS

Presenting author's disclosure statement:

Any relevant financial relationships? No
Any institutionally-contracted trials related to this submission?

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.